Status:
COMPLETED
Aripiprazole in Patients With Acute Mania
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborating Sponsors:
Otsuka America Pharmaceutical
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to test the safety \& efficacy of aripiprazole in patients with Bipolar Mania for a period of at least 12 weeks.
Eligibility Criteria
Inclusion
- Primary diagnosis of Acute Bipolar I Mania
Exclusion
- Patients with a DSM-IV diagnosis other than Bipolar I Mania
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
615 Patients enrolled
Trial Details
Trial ID
NCT00095511
Start Date
June 1 2004
End Date
May 1 2007
Last Update
November 11 2013
Active Locations (38)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Tuscaloosa, Alabama, United States
2
Local Institution
Scottsdale, Arizona, United States
3
Local Institution
Cerritos, California, United States
4
Local Institution
Garden Grove, California, United States